SGC-2085

N/A

Report date: 2023/09/14 13:35:07
NME

Base Information

Drug NameSGC-2085
Drug Alias NameSGC-2085
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-arginine methyltransferase CARM1 inhibitors
TargetsHistone-arginine methyltransferase CARM1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Toronto, Toronto
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Toronto, Toronto
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A